Pulmonary aspergillosis: diagnosis and treatment

[1]  J. Guillot,et al.  Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France. , 2015, Medical mycology.

[2]  DR DHIRAJ B NIKUMBH,et al.  Cytodiagnosis of Sinonasal Aspergillosis - A Case Report with Brief Review of Literature , 2015 .

[3]  E. Mylonakis,et al.  Diagnosis of invasive aspergillosis: recent developments and ongoing challenges , 2015, European journal of clinical investigation.

[4]  M. Bassetti,et al.  Current and future therapies for invasive aspergillosis. , 2015, Pulmonary pharmacology & therapeutics.

[5]  J. Boelens,et al.  Nationwide Surveillance of Azole Resistance in Aspergillus Diseases , 2015, Antimicrobial Agents and Chemotherapy.

[6]  A. Chowdhary,et al.  Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia , 2015, Front. Microbiol..

[7]  J. Buer,et al.  Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany. , 2015, The Journal of antimicrobial chemotherapy.

[8]  P. Le Pape,et al.  First Description of Azole-Resistant Aspergillus fumigatus Due to TR46/Y121F/T289A Mutation in France , 2015, Antimicrobial Agents and Chemotherapy.

[9]  S. Okoth,et al.  Identification Key for Aspergillus Species Isolated from Maize and Soil of Nandi County, Kenya , 2015 .

[10]  Z. Wan,et al.  The Diagnosis of Invasive and Noninvasive Pulmonary Aspergillosis by Serum and Bronchoalveolar Lavage Fluid Galactomannan Assay , 2015, BioMed research international.

[11]  Beatriz Peral-Cagigal,et al.  Invasive maxillary sinus aspergillosis: A case report successfully treated with voriconazole and surgical debridement , 2014, Journal of clinical and experimental dentistry.

[12]  H. Mirhendi,et al.  Molecular characterization of Aspergillus infections in an Iranian educational hospital using RAPD-PCR method , 2014, Iranian journal of basic medical sciences.

[13]  J. Latgé,et al.  The Volatome of Aspergillus fumigatus , 2014, Eukaryotic Cell.

[14]  K. Seifert,et al.  Aspergillus, Penicillium and Talaromyces isolated from house dust samples collected around the world , 2014, Studies in mycology.

[15]  R. Gorton,et al.  Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. , 2014, The Journal of antimicrobial chemotherapy.

[16]  A. Shah,et al.  Allergic aspergillosis of the respiratory tract , 2014, European Respiratory Review.

[17]  M. Netea,et al.  Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis , 2014, PloS one.

[18]  A. Chowdhary,et al.  Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview , 2014, Critical reviews in microbiology.

[19]  F. Damatta,et al.  Sustained Photosynthetic Performance of Coffea spp. under Long-Term Enhanced [CO2] , 2013, PloS one.

[20]  A. Vasavada,et al.  Microscopic Evaluation, Molecular Identification, Antifungal Susceptibility, and Clinical Outcomes in Fusarium, Aspergillus and, Dematiaceous Keratitis , 2013, BioMed research international.

[21]  A. Amorim,et al.  SNaPAfu: A Novel Single Nucleotide Polymorphism Multiplex Assay for Aspergillus fumigatus Direct Detection, Identification and Genotyping in Clinical Specimens , 2013, PloS one.

[22]  M. Badawy,et al.  Evaluation of pulmonary fungal diseases in patients with fungal rhino-sinusitis , 2013 .

[23]  F. V. van Tiel,et al.  Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  S. Walsh,et al.  Airway and parenchymal manifestations of pulmonary aspergillosis. , 2013, Respiratory medicine.

[25]  D. Denning,et al.  Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[26]  M. Christner,et al.  cyp51A-Based Mechanisms of Aspergillus fumigatus Azole Drug Resistance Present in Clinical Samples from Germany , 2013, Antimicrobial Agents and Chemotherapy.

[27]  D. Denning,et al.  Voriconazole resistance in Aspergillus fumigatus: should we be concerned? , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  P. Escribano,et al.  Is Azole Resistance in Aspergillus fumigatus a Problem in Spain? , 2013, Antimicrobial Agents and Chemotherapy.

[29]  P. Escribano,et al.  Evaluation of MycAssay™ Aspergillus for Diagnosis of Invasive Pulmonary Aspergillosis in Patients without Hematological Cancer , 2013, PloS one.

[30]  M. Bougnoux,et al.  Azole resistant Aspergillus fumigatus: an emerging problem. , 2013, Medecine et maladies infectieuses.

[31]  C. Thornton,et al.  Evaluation of Real-Time PCR, Galactomannan Enzyme-Linked Immunosorbent Assay (ELISA), and a Novel Lateral-Flow Device for Diagnosis of Invasive Aspergillosis , 2013, Journal of Clinical Microbiology.

[32]  R. Barton.  Laboratory Diagnosis of Invasive Aspergillosis: From Diagnosis to Prediction of Outcome , 2013, Scientifica.

[33]  A. Karaman,et al.  Invasive Aspergillus infection localized to the gastric wall: report of a case , 2012, Surgery Today.

[34]  B. Ganai,et al.  Identification of some Aspergillus species isolated from Dal Lake, Kashmir by traditional approach of morphological observation and culture , 2012 .

[35]  N. Berkova,et al.  Innate Immunity and the Role of Epithelial Barrier During Aspergillus fumigatus Infection , 2012, Current immunology reviews.

[36]  V. Cottin,et al.  Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[37]  Y. Niu,et al.  Voriconazole used for Treatment of Tracheobronchial Aspergillosis: A Report of Two Cases , 2012 .

[38]  Shyama Jain,et al.  Invasive maxillary aspergillosis masquerading as malignancy in two cases: Utility of cytology as a rapid diagnostic tool , 2012, Journal of cytology.

[39]  C. Viscoli,et al.  ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients , 2012, Bone Marrow Transplantation.

[40]  D. Denning,et al.  Voriconazole and Posaconazole Improve Asthma Severity in Allergic Bronchopulmonary Aspergillosis and Severe Asthma with Fungal Sensitization , 2012, The Journal of asthma : official journal of the Association for the Care of Asthma.

[41]  A. Chandr,et al.  Allergic bronchopulmonary aspergillosis--a clinical review. , 2012, The Journal of the Association of Physicians of India.

[42]  H. Xu,et al.  Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from China. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[43]  H. Dorfman,et al.  Aspergillus osteomyelitis of the proximal humerus: a case report , 2012, Skeletal Radiology.

[44]  R. Porcher,et al.  The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. , 2012, Blood.

[45]  A. Chowdhary,et al.  Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India. , 2012, The Journal of antimicrobial chemotherapy.

[46]  M. Björkholm,et al.  Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia , 2012, Infection.

[47]  C. Lass‐Flörl.  Triazole Antifungal Agents in Invasive Fungal Infections , 2011, Drugs.

[48]  P. Burgel,et al.  High Prevalence of Azole-Resistant Aspergillus fumigatus in Adults with Cystic Fibrosis Exposed to Itraconazole , 2011, Antimicrobial Agents and Chemotherapy.

[49]  W. F. Wright,et al.  (1–3)-β-D-Glucan Assay: A Review of its Laboratory and Clinical Application , 2011 .

[50]  Ž. Eri,et al.  Chronic necrotizing pulmonary aspergillosis. , 2011, Vojnosanitetski pregled.

[51]  D. Denning,et al.  Azole Antifungal Resistance Today: Focus on Aspergillus , 2011, Current infectious disease reports.

[52]  A. Soubani,et al.  Pulmonary aspergillosis: a clinical review , 2011, European Respiratory Review.

[53]  A. Chakrabarti,et al.  Invasive aspergillosis in developing countries. , 2011, Medical mycology.

[54]  M. Falagas,et al.  β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[55]  E. Alves,et al.  Identification of fungi of the genus Aspergillus section nigri using polyphasic taxonomy. , 2011 .

[56]  S. Roberts,et al.  Efficacy and safety of posaconazole for chronic pulmonary aspergillosis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[57]  S. Kohno,et al.  Posaconazole for chronic pulmonary aspergillosis: the next strategy against the threat of azole-resistant Aspergillus infection. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[58]  S. Kohno,et al.  Chronic aspergillus infections of the respiratory tract: diagnosis, management and antifungal resistance , 2010, Current opinion in infectious diseases.

[59]  D. Denning,et al.  Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma , 2010, European Respiratory Journal.

[60]  T. Peláez,et al.  Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[61]  Hojoong Kim,et al.  Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[62]  J. Stout,et al.  Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis , 2010, Journal of medical microbiology.

[63]  B. Segal,et al.  Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications. , 2010, Current opinion in pulmonary medicine.

[64]  P. Hofman,et al.  Usefulness of molecular biology performed with formaldehyde-fixed paraffin embedded tissue for the diagnosis of combined pulmonary invasive mucormycosis and aspergillosis in an immunocompromised patient , 2010, Diagnostic pathology.

[65]  D. Denning,et al.  zole-resistance in Aspergillus: Proposed nomenclature and breakpoints , 2009 .

[66]  D. Murdoch,et al.  Detection of 2-pentylfuran in the breath of patients with Aspergillus fumigatus. , 2009, Medical mycology.

[67]  Raoul Herbrecht,et al.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[68]  A. Soubani,et al.  Pulmonary aspergillosis: a clinical update. , 2007, QJM : monthly journal of the Association of Physicians.

[69]  C. Heussel,et al.  Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[70]  Gary E Erwin,et al.  Case Report: Allergic Bronchopulmonary Aspergillosis and Allergic Fungal Sinusitis Successfully Treated with Voriconazole , 2007, The Journal of asthma : official journal of the Association for the Care of Asthma.

[71]  D. Denning,et al.  Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis. , 2006, The American journal of medicine.

[72]  D. Paterson,et al.  Intrapulmonary Penetration of Voriconazole in Patients Receiving an Oral Prophylactic Regimen , 2006, Antimicrobial Agents and Chemotherapy.

[73]  T. Patterson.  Advances and challenges in management of invasive mycoses , 2005, The Lancet.

[74]  S. Bhargava,et al.  Treatment of Allergic Bronchopulmonary Aspergillosis with Fluconazole and Itraconazole. , 2004, Medical journal, Armed Forces India.

[75]  J. Perfect,et al.  Voriconazole treatment for less-common, emerging, or refractory fungal infections. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[76]  D. Caillot.  Intravenous Itraconazole followed by Oral Itraconazole for the Treatment of Amphotericin-B-Refractory Invasive Pulmonary Aspergillosis , 2003, Acta Haematologica.

[77]  Richard Sylvester,et al.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. , 2002, The New England journal of medicine.

[78]  D. Bates,et al.  Mortality and costs of acute renal failure associated with amphotericin B therapy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[79]  A. Degraff,et al.  A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. , 2000, The New England journal of medicine.

[80]  D. Denning.  Therapeutic outcome in invasive aspergillosis. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[81]  I. D. Conte,et al.  Tracheobronchial aspergillosis in a patient with AIDS treated with aerosolized amphotericin B combined with itraconazole , 1996, Mycoses.

[82]  M. Richardson,et al.  Fungal Infection: Diagnosis and Management , 1993 .

[83]  M. Okudaira,et al.  Fungal infections in cancer patients: An international autopsy survey , 1992, European Journal of Clinical Microbiology and Infectious Diseases.

[84]  M. Richardson,et al.  Treatment of pulmonary aspergilloma with itraconazole. , 1991, Thorax.

[85]  K. Beule,et al.  The Treatment of Aspergillosis and Aspergilloma with Itraconazole, Clinical Results of an Open International Study (1982 ‐ 1987)/Die Behandlung der Aspergillose und des Aspergilloms mit Itraconazol, Klinische Ergebnisse einer offenen internationalen Studie (1982 ‐ 1987) , 1988, Mycoses.

[86]  B. Strom,et al.  Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. , 1984, Annals of internal medicine.

[87]  W. Gefter,et al.  "Semi-invasive" pulmonary aspergillosis: a new look at the spectrum of aspergillus infections of the lung. , 1981, Radiology.

[88]  K. Hinson,et al.  Broncho-pulmonary aspergillosis; a review and a report of eight new cases. , 1952, Thorax.

[89]  S. Shivani,et al.  Prevalence and fungal profile of pulmonary aspergillosis in immunocompromised and immunocompetent patients of a tertiary care hospital , 2014 .

[90]  G. Maschmeyer,et al.  Invasive Aspergillosis , 2012, Drugs.

[91]  R. L. Ciubotaru,et al.  Invasive pulmonary aspergillosis in an immunocompetent patient , 2011 .

[92]  A. Chakrabarti,et al.  Role of inhaled corticosteroids in the management of serological allergic bronchopulmonary aspergillosis (ABPA). , 2011, Internal medicine.

[93]  P. Greally,et al.  Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. , 2009, Irish medical journal.

[94]  M. J. Martínez,et al.  Prolonged therapeutic response to voriconazole in a case of allergic bronchopulmonary aspergillosis , 2007 .

[95]  W. Caras,et al.  Chronic necrotizing pulmonary aspergillosis: pathologic outcome after itraconazole therapy. , 1996, Mayo Clinic proceedings.